Profile: Mauna Kea Technologies SA (MKEA.PA)

MKEA.PA on Paris Stock Exchange

5.23EUR
4:23am EDT
Price Change (% chg)

€0.05 (+0.97%)
Prev Close
€5.18
Open
€5.20
Day's High
€5.27
Day's Low
€5.13
Volume
4,354
Avg. Vol
49,518
52-wk High
€15.37
52-wk Low
€4.68

Search Stocks
Mauna Kea Technologies, also known as Mauna Kea Technologies SA, is a France-based company active in the healthcare business sector. It specializes in designing, developing, and selling medical imaging tools and systems. The Company’s products, used mainly in endoscopy, are intended for viewing and detecting deficiencies in the gastrointestinal and respiratory systems, primarily focusing on patients suffering from cancer. The main product offered by the Company is Cellvizio, a probe-based Confocal Laser Endomicroscopy (pCLE) which is a system providing physicians and researchers with high resolution cellular images of tissue in a real-time structure. The Company has marketing authorizations in Thailand, the United Kingdom, the USA, Brazil, Chile, South Korea, Poland, Russia and Saudi Arabia, among others.

Company Address

Mauna Kea Technologies SA

9, rue d'Enghien
Paris     75010
P: +3314.8240345
F: +3314.8241218

Company Web Links

Search Stocks